VERA
Vera Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.44B
P/E Ratio
—
EPS
$-5.54
Beta
0.95
52W High
$56.05
52W Low
$18.76
50-Day MA
$38.79
200-Day MA
$36.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vera Therapeutics Inc
Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-382.89M |
| Operating Margin | 0.00% |
| Return on Equity | -71.30% |
| Return on Assets | -38.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.97 |
| Price-to-Book | 4.89 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $71.78M |
| Float | $52.01M |
| % Insiders | 0.88% |
| % Institutions | 111.09% |
Historical Volatility
HV 10-Day
69.31%
HV 20-Day
55.58%
HV 30-Day
49.24%
HV 60-Day
50.29%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($78.00 target)
1
Strong Buy12
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026